Approximately 18% of epithelial ovarian cancer cases, particularly high-grade serous carcinomas, are due to inherited mutations in BRCA1/2 genes; these mutations account for almost 40% of ovarian cancer cases in women with a family history of the disease (Couch et al., 2014). This evidence concerns the gene BRCA1 and ovarian carcinoma.